20/20 Biolabs, Inc.
AIDX
$1.46
$0.096.33%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -42.49% | -- | -- | -74.96% | -56.38% |
| Total Receivables | 47.82% | -- | -- | -- | 96.66% |
| Inventory | 146.19% | -- | -- | -- | -22.24% |
| Prepaid Expenses | 90.27% | -- | -- | -- | -16.81% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -27.68% | -- | -- | -- | -52.70% |
|
|
|||||
| Total Current Assets | -27.68% | -- | -- | -- | -52.70% |
| Net Property, Plant & Equipment | -25.54% | -- | -- | -- | -24.50% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -5.17% | -- | -- | -- | -5.19% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 845.00% | -- | -- | -- | -55.41% |
| Total Assets | 15.43% | -- | -- | -- | -43.71% |
|
|
|||||
| Total Accounts Payable | 133.28% | -- | -- | -- | 3.33% |
| Total Accrued Expenses | 126.72% | -- | -- | -- | 48.95% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 51.24% | -- | -- | -- | 1.16% |
| Total Finance Division Other Current Liabilities | 18.66% | -- | -- | -- | 84.58% |
| Total Other Current Liabilities | 18.66% | -- | -- | -- | 84.58% |
| Total Current Liabilities | 81.77% | -- | -- | -- | 33.96% |
|
|
|||||
| Total Current Liabilities | 81.77% | -- | -- | -- | 33.96% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -27.47% | -- | -- | -- | -19.74% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1,070.80% | -- | -- | -- | -- |
| Total Liabilities | 99.94% | -- | -- | -- | -0.07% |
|
|
|||||
| Common Stock & APIC | 7.05% | -- | -- | -- | 9.92% |
| Retained Earnings | -12.67% | -- | -- | -- | -23.17% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -104.55% | -- | -- | -92.82% | -65.61% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.85% | -- | -- | -- | 1.30% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.85% | -- | -- | 2.16% | 1.30% |
|
|
|||||
| Total Common Equity | -104.55% | -- | -- | -92.82% | -65.61% |
| Total Preferred Equity | 0.85% | -- | -- | 2.16% | 1.30% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -101.28% | -- | -- | -91.80% | -64.89% |
|
|
|||||